Study Status: NOT_YET_RECRUITING
Recruit Status: NOT_YET_RECRUITING
Study Type: INTERVENTIONAL
Official Title: Pilot Study to Evaluate Docosahexaenoic Acid as Treatment for Residual Amblyopia
Brief Summary: This study evaluates the addition of docosahexaenoic acid (DHA) to eye patching in the treatment of residual amblyopia in children ages 3 to 18 years old.
Two thirds of participants will receive DHA along with eye patching, while one third of participants will receive a placebo along with eye patching.